- Home
- PLAG vs SNPX Comparison
PLAG vs SNPX Comparison
Compare PLAG & SNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLAG
- SNPX
- Stock Information
- Founded
- PLAG 1986
- SNPX 2012
- Country
- PLAG United States
- SNPX United States
- Employees
- PLAG N/A
- SNPX N/A
- Industry
- PLAG Packaged Foods
- SNPX Medicinal Chemicals and Botanical Products
- Sector
- PLAG Consumer Staples
- SNPX Health Care
- Exchange
- PLAG Nasdaq
- SNPX Nasdaq
- Market Cap
- PLAG N/A
- SNPX 3.3M
- IPO Year
- PLAG N/A
- SNPX N/A
- Fundamental
- Price
- PLAG $1.32
- SNPX $2.37
- Analyst Decision
- PLAG
- SNPX Strong Buy
- Analyst Count
- PLAG 0
- SNPX 1
- Target Price
- PLAG N/A
- SNPX $14.00
- AVG Volume (30 Days)
- PLAG 46.1K
- SNPX 7.8K
- Earning Date
- PLAG 05-14-2025
- SNPX 05-14-2025
- Dividend Yield
- PLAG N/A
- SNPX N/A
- EPS Growth
- PLAG N/A
- SNPX N/A
- EPS
- PLAG N/A
- SNPX N/A
- Revenue
- PLAG $16,965,260.00
- SNPX N/A
- Revenue This Year
- PLAG N/A
- SNPX N/A
- Revenue Next Year
- PLAG N/A
- SNPX N/A
- P/E Ratio
- PLAG N/A
- SNPX N/A
- Revenue Growth
- PLAG N/A
- SNPX N/A
- 52 Week Low
- PLAG $1.00
- SNPX $2.15
- 52 Week High
- PLAG $5.52
- SNPX $6.22
- Technical
- Relative Strength Index (RSI)
- PLAG 39.40
- SNPX 33.20
- Support Level
- PLAG $1.00
- SNPX $2.28
- Resistance Level
- PLAG $1.70
- SNPX $2.78
- Average True Range (ATR)
- PLAG 0.21
- SNPX 0.16
- MACD
- PLAG -0.01
- SNPX -0.02
- Stochastic Oscillator
- PLAG 29.09
- SNPX 24.23
About SNPX Synaptogenix Inc.
Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.